The APOGEE-Net/CanGèneTest Research and Knowledge Network on Genetic Health
Services and Policy represents a merger and expansion of two multidisciplinary initiatives in health services research in genetics: APOGEE-Net and CanGèneTest.
APOGEE-Net/CanGèneTest was formed in 2009 with five-year funding from CIHR's Institute of Genetics and Institute of Health Services and Policy Research. It aims to maintain and further develop the links forged by CanGèneTest and APOGEE-Net between researchers in genetics, decision-makers at different levels in the health care system, health care professionals and the general public. The general objective of the Research and Knowledge Network is to streamline the technology transfer of clinically useful and cost/effective genetic innovations towards the health care system and support the development of evidence-informed health policies. It will streamline the translation processes of clinically useful genetic innovations from the research bench to the Canadian population. Research and knowledge translation activities aim to assist decision-making at all levels in four areas:
1) assessment of new genetic technologies;
2) models of service delivery;
3) genetics in primary care; and
4) knowledge and technology transfer.
The Research and Knowledge Network is pan-Canadian in scope and covers the whole spectrum of research expertise needed to validate and transfer genetic innovations into the health care system. The team is comprised of 29 researchers, six decision-makers and four collaborators from Canada and abroad. The team includes members of CanGèneTest and APOGEE-Net but also welcomes new members.